Hzymes Biotechnology Co., Ltd. of Shanghai at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Hzymes Biotechnology Co., Ltd.

No. 701&702, Building 3, Fengchuan Park No. 1588 Huhang Road, Fengxian District, 201424 Shanghai
China
Telephone +86 21 31787622

Contact

Shuai Han

Marketing Director

Shanghai, China

Phone
+86 18628170611

Email
hanshuai@hzymes.com

Yucca Wang

Overseas Sales Manager

Shanghai, China

Phone
+86 13641941619

Email
yucca.wang@hzymes.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 01  Electromedical equipment / medical technology
  • 01.11  Other equipment for electromedicine / medical technology
  • 03  Diagnostic tests
  • 03.01  Clinical chemistry
  • 03.01.01  Glucose testing
  • 03  Diagnostic tests
  • 03.01  Clinical chemistry
  • 03.01.05  Other equipment for clinical chemistry
  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

Our products

Product category: DNA testing

Proteinase K

Proteinase K from the fungus Tritirachium album is a nonspecific serine protease useful for general digestion of proteins. Removal of endogenous nucleases during the preparation of DNA and RNA; preparation of tissue sections for in situ hybridization.

More Less

Product category: Glucose testing

Glycohemoglobin A1c (HbA1c) Enzymatic

In vitro test for the quantitative determination of HbA1c concentration in human whole blood on photometric systems. HbA1c is a product of hemoglobin (Hb) that produces a slow and continuous non-enzymatic glycation reaction under the action of high blood glucose. Glucose modifies hemoglobin specifically in its n-terminal valine residue to form glycated hemoglobin. Under normal physiological conditions, the production of non-enzymatic glycosylation reaction products is positively proportional to the concentration of reactants. Since hemoglobin concentration remains relatively stable, glycosylation levels are mainly dependent on glucose concentration and are also related to the length of hemoglobin and glucose exposure. Therefore, HbA1c is a good indicator for the average blood glucose level of patients at 2 to 3 months.

More Less

Product category: Glucose testing

Glucose Dehydrogenase (FAD)

Glucose dehydrogenase (GDH) is a kind of oxidoreductase which catalyzes the oxidation of glucose to gluconolactone. It has been widely used in the fields of blood glucose detection, biofuel cell, implantable cardiac pacemaker and industrial glucose content monitoring.

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

Lumigen APS-5

It is mainly used for immunoassay, such as diagnosis of tumor markers, infectious diseases, endocrine function, hormone and so on

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

Thrombin Chromogenic substrate S-2238

Thrombin chromogenic substrate S-2238 has a wide range of applications, such as: to detect the ratio of anti FXa activity to anti FIIa activity of unclassified heparin and low molecular weight heparin, accurately detect the anti FIIa activity of unclassified heparin and low molecular weight heparin, evaluate the anti FIIa activity of chemical synthetic substances or tissue extracts, and detect the concentration of antithrombin in blood samples to diagnose antithrombin deficiency To measure the concentration of heparin in blood during operation, and to produce the kit for automatic hematology analyzer.

More Less

Product category: DNA testing

Bst DNA Polymerase, Large Fragment

Bst DNA Polymerase, Large Fragment is the portion of the Bacillus stearothermophilus DNA Polymerase protein that contains the 5´→3´polymerase activity, but lacks 5´→3´exonuclease activity. This product uses E. coli expression and can be suitable for isothermal amplification.

More Less

Product category: Other equipment for electromedicine / medical technology

D-erythro-Sphingosine

A01050

More Less

Product category: Other equipment for electromedicine / medical technology

Maltohexaose

A01058

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

Maltoheptaose

A01059

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

Maltooctaose

A01061

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

PNGase F

EN01022

More Less

Product category: DNA testing

Taq DNA Polymerase

HotStarTaq DNA Polymerase, including buffers and reagents, should be stored immediately upon receipt at -30 to -15°C in a constant-temperature freezer.

More Less

Product category: Other equipment for clinical chemistry, Other equipment for electromedicine / medical technology

Gal-G2-CNP

ES01011

More Less

Company news

Date

Topic

04 Nov 2020

The Mass Production and Volume Export of Hzymes Biological Technology Co., Ltd

Founded in 2015, Hzymes is a high-tech enterprise specializing in the research and development, production, application, and technical services of enzymes.


Hzymes has owned technology platforms for screening and expression of enzyme, molecule modification of enzyme, organic custom synthesis, synthetic biology, etc. Hzymes has provided products to more than 80 domestic in vitro diagnostic reagent manufacturers and 42 foreign partners in 25 countries.

 

By the year of 2020, Hzymes’ top-selling products including Proteinase K (molecular raw materials) and Glycated Hemoglobin (reagents) are in mass production and volume export. The trading sales of top-selling products in 2020 amount to 50% of the total, which is a higher mark stone to encouraging us offer better products, better services to our customers from more than 30 countries.

 

Let more people enjoy happy life is always the source of power to keep us going. We are diligent and delighted to deliver accurate and precise results through our enzyme molecules and reagents to help people live better life all around the world.

 

More Less

13 Oct 2020

Hzymes Biological Technology Co., Ltd Passes the Certification of ISO 9001:2015 Quality Management System

Earlier before that, on September 25, 2017, Hzymes received the certification that is issued by the Quality Management Certification Authority. With our persistent efforts on quality production, the Quality Management System Certificate of Conformity is renewed in 2020, which marks that Hzymes has successfully providing warranties for many years and will continuously to do so.

 

ISO 9001:2015 quality management system document improvement is a complex and cumbersome process, the company from the market and actual situation, to supplement and improve all documents of the quality management system. Hzymes has scientific methods and means of quality management and quality assurance, and its internal management level has been constantly improved. Especially the documentation of internal management, which clarifies the norms and responsibilities for each post, makes the whole quality work knowable, visible and verifiable, and guarantees the quality management of products.

 

As a production-oriented enterprise that masters the core technology of high-end diagnostic enzyme research and development, Hzymes has reached international standards in the integration of various management systems. Upholding the rigorous spirit of "Each Molecule Promises Accuracy ", Hzymes will be able to continuously and steadily provide the market with qualified products that meet customer expectations and satisfy customers.

 

Hzymes will take this as a new start and make new contribution to the in vitro diagnostic market.

More Less

23 Aug 2020

The Third IVD Raw Material Components Forum has successfully held.

From the editor:

Dr. Yang Guangyu, chairman of Hanhai New Enzyme Co., LTD., made a theme report on “the integrated creation of enzyme preparations for in vitro diagnosis”. As a key raw material supplier of IVD industry integrating research, development, production and marketing, Hanhai New Enzyme is responsible for accelerating the realization of the substitution of core IVD raw materials for the creation of POCT “China Core” to safeguard the national industrial safety.

 

Sponsored by China Medical Device Industry Association (CAMDI) Testing Equipment Raw Materials and Components Professional Committee, the third IVD Raw materials and Components Forum was held on August 22, 2020 in multi-function hall A, conference room 205, conference center, Primus Hotel, Nanchang International Expo City.

At present, the domestic in vitro diagnostic upstream raw materials are rapidly improving in quality and brand development. The third IVD raw material components forum invited many experts, scholars and entrepreneurs whom are the head of general manager of the upstream raw materials, well-known enterprise executives, head of r&d director and professors from elite universities. This forum is communicating and discussing on following topics: the status quo of China's in vitro diagnostic key raw materials, the challenges and opportunities, in vitro diagnostic upstream raw materials (antigen antibody enzyme probe primers microspheres photoelectric component liquid road) development and application of in vitro diagnostic, how downstream enterprises choose the core raw materials and components in vitro diagnostic, how do end users conduct clinical application and evaluation.

The forum is hosted by the President of the Clinical Medicine Branch of Chinese Society of Biochemistry and Molecular Biology, Chairman of Medical Laboratory Engineering Branch, Chinese Biomedical Engineering Society, China association for medical devices industry rapid testing (POCT) branch committee, director of Beijing Clinical Engineering Research Center for Immunoreagents, professor of Experimental Diagnosis Center, Beijing Tiantan Hospital affiliated to Capital Medical University, professor Kang Xixiong, PhD supervisor of Beihang University, professor, School of Biomedical Engineering, Shenzhen University, director of in Vitro Diagnostic Instruments Research Center, Shenzhen University, director of In vitro diagnostic instrument Generic Technology Service Platform in Shenzhen, Professor Zhang Huisheng, Vice chairman of Medical Laboratory Engineering Branch of Chinese Biomedical Engineering Society, Mr. Wang Yongqiang, CEO of Ocean NanoTech LLC take charge of the chairman of the forum. 

     

More Less

28 Apr 2020

With the strike of COVID - 19, is the Proteinase OK or Knock out?

Recently,Covid-19 has exploded worldwide, and the coronavirus detection nucleic acid detection kit which is seeing as golden standard is in short supply. Among which, protease K is an important component used for sample pretreatment, and it is even more difficult to supply

Hanzyme is determined to become the world-class special enzyme products and service providers, aiming at high-challenge product like proteinase K. The purpose is not only to achieve first class product quality, but also to achieve the first class output. Our goal is to brand the Coronavirus detection kit that made in China with the brand of our independent core raw material supplier.

Meantime, we are developing Coronavirus nucleic acid detection kit, the other enzyme materials as well as dNTP materials.

We believe with the contribution of the joint efforts of all enterprises in the in vitro diagnostic industry, China’s in vitro diagnostic products can contribute China's strength to the global fight against coVID-19. There will be no shortage of core raw materials to lose advantages.

 

More Less

09 Apr 2020

Live Up to Blossom Years and Strive Forward

   During the spring festival of 2020, the Coronavirus epidemic has quickly spreading all over the world. To facing the sudden change, Shanghai Hanover Biotechnology Co., LTD. (hereinafter referred to as Hanover) Hanhai New Enzyme R&D and marketing center of Shanghai, took fully respond to promote the operation preparation of R & D and management center in Fengchuang Valley.   
   As a global supplier of IVD (In Vitro Diagnostic) raw material, Hanhai New Enzyme Biotechnology is devoted to providing high quality product and efficient solutions for global manufacturer of In Vitro Diagnostic Reagents. In medical field, 70% of diagnosis and treatment decisions are make with the help of In Vitro Diagnostic Products. According to the estimation by Evaluate MedTdch, the global in vitro diagnostic market scale reached to $70 billion, core material market size achieved over $10.5 billion. In 2019, China’s in vitro diagnostic market size is around $80 billion, vital raw material market scale is at $12 billion. Most of the companies can provide these core raw materials (key enzyme antigen antibody color substrate, etc.) are foreign enterprises.

Relying on our own research and development team, we have developed more than 60 kinds of core enzymes for in vitro diagnostic reagents using the enzyme function evolution and high-throughput screening technology platform, covering more than 80% of the product lines in the biochemical field. At the same time, the application environment of various core enzymes and the best formula to explore, to provide customers with the overall solution from raw materials to the process. Among them, HbA1c test reagent has been approved by European customers. At the same time, the marketing team has been constantly exploring customer needs and developing chemiluminescence substrates (APS-5) to replace imported products, which have been recognized by domestic listed in vitro diagnostic enterprises. The officially operation of Shanghai Hanover Biotechnology research & management center will speed up the company in various fields of in vitro diagnostic core raw material layout, also provide support for the comprehensive development of overseas market while facing the impact of the epidemic, but we believe that our these with independent research and development ability of enterprises in China can translate crisis into opportunity, seize the great opportunity for the development of health industry 

More Less

About us

Company portrait

Founded in 2015, Hzymes is a high-tech enterprise
specializing in the research and development, production,
application, and technical services of enzymes. 
 
Hzymes has owned technology platforms for screening and
expression of enzyme, molecule modification of enzyme, organic custom synthesis, synthetic biology, etc. Hzymes has provided products to more than 80 domestic in vitro diagnostic reagent manufacturers and 42 foreign partners in 25 countries.
 
Let more people enjoy happy life is always the source of power
to keep us going. We are diligent and delighted to deliver accurate and precise results through our enzyme molecules and
reagents to help people live better life all around the world.

hzymes-globle.com

Company data

Sales volume 50-99 Mio US $
Export content max. 50%
Number of employees 100-499
Foundation 2015
Area of business Diagnostics

Company information as a PDF file